first week semaglutide weight loss Results after 4 weeks on STARTING MY SEMAGLUTIDE JOURNEY *week

A study published last summer by JAMA Oncology looked at GLP-1 use and 14 obesity-related cancers and found that while the weight-loss drug lowered the risk of most cancers, there was a nonsignificant increased risk of kidney cancer particularly among people younger than 65

Birth issues: The FDA recommends GLP-1s not be taken during pregnancy and be discontinued at least two months prior to pregnancy, because animal studies demonstrate it may cause higher rates of miscarriage and birth defects

Wegovy is FDA-approved for long-term weight management in adults who are fat or overweight and who suffer from at least one weight-related illness, such as type 2 diabetes, high blood pressure, or high cholesterol

Diagnosis and initial management of kidney stones